China SXT Pharmaceuticals (SXTC) Debt Ratio (2018 - 2025)
China SXT Pharmaceuticals has reported Debt Ratio over the past 8 years, most recently at 0.0 for Q3 2025.
- For Q3 2025, Debt Ratio fell 98.86% year-over-year to 0.0; the TTM value through Sep 2025 reached 0.0, down 98.86%, while the annual FY2025 figure was 0.0, 81.62% down from the prior year.
- Debt Ratio for Q3 2025 was 0.0 at China SXT Pharmaceuticals, down from 0.0 in the prior quarter.
- Over five years, Debt Ratio peaked at 0.35 in Q1 2021 and troughed at 0.0 in Q1 2022.
- A 5-year average of 0.09 and a median of 0.03 in 2024 define the central range for Debt Ratio.
- Biggest five-year swings in Debt Ratio: skyrocketed 14661.97% in 2021 and later plummeted 99.9% in 2022.
- Year by year, Debt Ratio stood at 0.09 in 2021, then crashed by 99.64% to 0.0 in 2022, then soared by 10541.78% to 0.04 in 2023, then skyrocketed by 574.39% to 0.24 in 2024, then tumbled by 98.86% to 0.0 in 2025.
- Business Quant data shows Debt Ratio for SXTC at 0.0 in Q3 2025, 0.0 in Q1 2025, and 0.24 in Q3 2024.